ABLD:PA AbL Diagnostics SA

EUR 2.90 0.00 0
Icon

AbL Diagnostics SA (ABLD:PA) Stock Analysis and Price Targets

COMMON STOCK | Health Information Services | PA
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Neutral

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

EUR 2.90

0.00 (0.00)%

EUR 0.05B

199.00

N/A

N/A

Icon

ABLD:PA

AbL Diagnostics SA (EUR)
COMMON STOCK | PA
EUR 2.90
0.00 0
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Neutral

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

EUR 0.05B

N/A

EUR 2.90

AbL Diagnostics SA (ABLD:PA) Stock Forecast

N/A

Based on the AbL Diagnostics SA stock forecast from 0 analysts, the average analyst target price for AbL Diagnostics SA is not available over the next 12 months. AbL Diagnostics SA’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of AbL Diagnostics SA is Neutral, which is based on 6 positive signals and 6 negative signals. At the last closing, AbL Diagnostics SA’s stock price was EUR 2.90. AbL Diagnostics SA’s stock price has changed by -8.81% over the past week, -8.81% over the past month and -59.15% over the last year.

No recent analyst target price found for AbL Diagnostics SA
No recent average analyst rating found for AbL Diagnostics SA

Company Overview AbL Diagnostics SA

ABL Diagnostics Société anonyme provides proprietary molecular biology assays and end-to-end solutions to be used for molecular detection by polymerase chain reaction (PCR) and through DNA sequencing in France and internationally. It offers genotyping through NGS and sanger seq...Read More

https://www.fauvet-girel.fr

42 rue Olivier MEtra, Paris, France, 75020

21

December

EUR

France

Adjusted Closing Price for AbL Diagnostics SA (ABLD:PA)

Loading...

Unadjusted Closing Price for AbL Diagnostics SA (ABLD:PA)

Loading...

Share Trading Volume for AbL Diagnostics SA Shares

Loading...

Compare Performance of AbL Diagnostics SA Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for ABLD:PA

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To AbL Diagnostics SA (Sector: Health Information Services )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
EQS:PA
Equasens Société anonyme +0.10 (+0.17%) EUR0.90B 19.04 12.50

ETFs Containing ABLD

Symbol Name ABLD's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About AbL Diagnostics SA (ABLD:PA) Stock

Stock Target Advisor's fundamental analysis for AbL Diagnostics SA's stock is Neutral.

Unfortunately we do not have enough data on ABLD:PA's stock to indicate if its a good dividend stock.

Unfortunately we do not have enough data on ABLD:PA's stock to indicate what its average analyst target is.

ABLD:PA stock's Price/Earning ratio is 29.00. Our analysis grades ABLD:PA stock's Price / Earning ratio at F. This means that ABLD:PA stock's Price/Earning ratio is above 60% of the stocks in the Health Information Services sector in the PA exchange. Based on this ABLD:PA may be a overvalued for its sector.

The last closing price of ABLD:PA's stock was EUR 2.90.

The most recent market capitalization for ABLD:PA is EUR 0.05B.

Unfortunately we do not have enough analyst data on ABLD:PA's stock to indicate whether its price will go up or not.

We can't find any ETFs which contains AbL Diagnostics SA's stock.

As per our most recent records AbL Diagnostics SA has 21 Employees.

AbL Diagnostics SA's registered address is 42 rue Olivier MEtra, Paris, France, 75020. You can get more information about it from AbL Diagnostics SA's website at https://www.fauvet-girel.fr.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...